55.72
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
Procept Biorobotics stock falls after CEO succession announcement - Investing.com Australia
Edwards Exec Larry Wood Departs for Procept BioRobotics - Orange County Business Journal
Leadership Change and Revenue Surge Shake PROCEPT BioRobotics - TipRanks
Procept BioRobotics (PRCT) Shares Drop Amid CEO Transition - GuruFocus
Edwards loses longtime TAVR leader Larry Wood - MedTech Dive
Procept BioRobotics stock down on CEO exit (PRCT:NASDAQ) - Seeking Alpha
What analysts say about PROCEPT BioRobotics Corporation stockUnmatched market gains - Autocar Professional
Procept BioRobotics CEO Reza Zadno reitiring, Larry Wood to succeed - MSN
PROCEPT BioRobotics Appoints New CEO Larry L. Wood - TipRanks
Procept Biorobotics CEO to retire, Edwards VP, TAVR head named as successor - MassDevice
Procept Biorobotics Corporation Announces Executive Changes - MarketScreener
Is PROCEPT BioRobotics Corporation stock a growth or value playFastest-growing stock picks - jammulinksnews.com
PROCEPT BioRobotics: Promising Growth Under New Leadership and Attractive Valuation - TipRanks
What's the outlook for PRCT's Q1 2025 earnings? - AInvest
Why did PRCT's Q3 earnings exceed forecasts? - AInvest
Larry Wood to join PROCEPT BioRobotics as CEO, company reports 48% revenue growth - Investing.com
Procept BioRobotics (PRCT) Exceeds Q2 Revenue Projections | PRCT Stock News - GuruFocus
Larry L. Wood Appointed CEO of PROCEPT BioRobotics; Company Pre-Announces 48% Revenue Growth for 2Q25 - Nasdaq
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to - GlobeNewswire
PROCEPT BioRobotics Achieves 48% Revenue Surge to $79.2M as Edwards Lifesciences Veteran Takes CEO Role - Stock Titan
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy - GlobeNewswire
What drives PROCEPT BioRobotics Corporation stock priceRapid-fire capital growth - jammulinksnews.com
Redefining Prostate Cancer Care: How PROCEPT BioRobotics' Aquablation Therapy Could Disrupt Urology and Unlock a $10B+ Market - AInvest
Is PROCEPT BioRobotics Corporation a good long term investmentMassive portfolio appreciation - jammulinksnews.com
PROCEPT BioRobotics Corporation Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com
Evaluating PROCEPT BioRobotics (PRCT) Ahead of Q2 2025 Earnings: A Strategic Buy Opportunity in Surgical Robotics? - AInvest
Procept Biorobotics shares rise 1.65% after-hours after announcing Q2 2025 earnings report date. - AInvest
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times
PROCEPT BioRobotics to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Quiver Quantitative
PROCEPT BioRobotics Corp (PRCT) stock falls 3.23% on July 21 - AInvest
PROCEPT BioRobotics Corp Shares Surge 3.68% Amid Analyst Predictions of 26.35% Upside - AInvest
Nisa Investment Advisors LLC Purchases 270 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Why PROCEPT BioRobotics Corporation stock is on top investor watchlistsExpert Trading Flow - Newser
how procept biorobotics corporation stock performs during market volatilityGroup Only Stock Signals - Newser
Morgan Stanley Lowers PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $68.00 - Defense World
Q2 EPS Estimate for PROCEPT BioRobotics Raised by Analyst - Defense World
Positive Outlook on PROCEPT BioRobotics Amid New Fee Schedule Developments for Aquablation - AInvest
Procept BioRobotics Receives Favorable CMS Updates and Reimbursement Stability - AInvest
Procept BioRobotics says Aquablation therapy assigned a Category I code - MSN
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $68 to $85 - 富途牛牛
Teacher Retirement System of Texas Has $646,000 Stock Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):